Drug Delivery for Movement Disorders

Neil Barua, Steven Gill

Research output: Chapter in Book/Report/Conference proceedingChapter in a book

4 Citations (Scopus)

Abstract

There has been substantial research interest in delivering therapeutic neurotrophic factors directly to the brain for the treatment of Parkinson's Disease (PD) and other movement disorders. Direct infusion of glial cell-line derived neurotrophic factor has been investigated in both pre-clinical models and clinical trials. In this chapter we discuss past and present research investigating the potential of direct drug delivery to the brain for the treatment of PD and other movement disorders.

Original languageEnglish
Title of host publicationCurrent Concepts in Movement Disorder Management
EditorsA Niranjan, L D Lunsford, R M Richardson
PublisherKarger Publishers
Pages243-252
Number of pages10
ISBN (Electronic)9783318062021
ISBN (Print)9783318062014
DOIs
Publication statusPublished - Jan 2018

Publication series

NameProgress in Neurological Surgery
PublisherKarger
Volume33
ISSN (Print)0079-6492

Fingerprint Dive into the research topics of 'Drug Delivery for Movement Disorders'. Together they form a unique fingerprint.

Cite this